Cureus, Choices and Challenges With Drug Therapy in Postural Orthostatic Tachycardia Syndrome: A Systematic Review
By A Mystery Man Writer
Description
The literature on pharmacologic treatments for postural orthostatic tachycardia syndrome (POTS) is inconsistent and unstandardized. Therefore, we aimed to evaluate choices in pharmacologic treatment options for POTS and the challenges encountered in the studies. We searched numerous databases like PubMed, Scopus, Embase, Web of Science, and Google Scholar for literature published before April 8, 2023. The search was done to retrieve potential peer-reviewed articles that explored drug therapy in POTS. Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines were used to conduct the systematic review. Of the 421 potential articles assessed, 17 met the inclusion criteria. Results demonstrated that pharmacologic treatment options for POTS were effective in reducing symptoms of POTS, but most of the studies were underpowered. Several were terminated due to various reasons. Midodrine ivabradine, bisoprolol, fludrocortisone, droxidopa, desmopressin, propranolol, modafinil, methylphenidate, and melatonin have been studied with positive impact but sample sizes that were low in the range of 10-50 subjects. Therefore, we concluded the treatment options effectively improve symptoms of POTS and increase orthostatic tolerance, but more evidence is needed as most studies had a low sample size and thus are underpowered.
Radhika Kotak - International Visiting Medical Student in Cardiology - Unicardio Medical Center
PDF] Postural tachycardia syndrome: a heterogeneous and multifactorial disorder.
Frontiers Postural orthostatic tachycardia syndrome and other related dysautonomic disorders after SARS-CoV-2 infection and after COVID-19 messenger RNA vaccination
JPM, Free Full-Text
Distinct Hemodynamic Responses That Culminate With Postural Orthostatic Tachycardia Syndrome - ScienceDirect
PDF) Alpha-2 Agonists in Children and Adolescents With Post-traumatic Stress Disorder: A Systematic Review
POTS Syndrome: Ultimate Patient Guide by Cardiologist • MyHeart
Autonomic Dysfunction And Postural Orthostatic Tachycardia, 49% OFF
Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection
Cureus, Benefits and Risks of Medications Used in the Management of Hypotension: A Review
Postural Orthostatic Tachycardia Syndrome in COVID-19
Impaired Endothelial Function in Patients With Postural Tachycardia Syndrome
Ivabradine in children with postural orthostatic tachycardia syndrome: a retrospective study, Cardiology in the Young
High Incidence of Autonomic Dysfunction and Postural Orthostatic Tachycardia Syndrome in Patients with Long COVID: Implications for Management and Health Care Planning - ScienceDirect
Understanding and Managing Postural Orthostatic Tachycardia Syndrome
from
per adult (price varies by group size)